Titlebook: GI Surgery Annual; Volume 26 T. K. Chattopadhyay (Editor-in-Chief),Peush Sahni, Book 2022 The Editor(s) (if applicable) and The Author(s),

quick-relievers

書(shū)目名稱(chēng)GI Surgery Annual影響因子(影響力)




書(shū)目名稱(chēng)GI Surgery Annual影響因子(影響力)學(xué)科排名




書(shū)目名稱(chēng)GI Surgery Annual網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱(chēng)GI Surgery Annual網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱(chēng)GI Surgery Annual被引頻次




書(shū)目名稱(chēng)GI Surgery Annual被引頻次學(xué)科排名




書(shū)目名稱(chēng)GI Surgery Annual年度引用




書(shū)目名稱(chēng)GI Surgery Annual年度引用學(xué)科排名




書(shū)目名稱(chēng)GI Surgery Annual讀者反饋




書(shū)目名稱(chēng)GI Surgery Annual讀者反饋學(xué)科排名

連累

Cholangiopancreaticoscopy: A Distinct Diagnostic and Therapeutic Tool in the Current Era,ng time. Per-oral cholangioscopy (POCS) using miniature endoscope, through the channel of a standard duodenoscope, was first described more than 40?years ago in the 1970s [1, 2]. The procedure never became popular because of fragile instruments, poor image quality, prolonged procedure time and the n

constitute

Non-cirrhotic Portal Fibrosis,a major proportion of patients with PHT especially in the younger age groups [1–3]. These are mainly extrahepatic portal venous obstruction (EHO), non-cirrhotic portal fibrosis (NCPF) and hepatic venous outflow tract obstruction (HVOTO). Although NCPF comprised 23 (8%–47%) patients with portal hyper

魅力

Progressive Familial Intrahepatic Cholestasis, bowel type of diarrhea not requiring any rehydration therapy. His pruritus was severe excoriating, interfering with his daily life, play, and schooling. He had an external biliary diversion surgery at the age of 6?years with temporary relief in pruritus for a year, but a decrease in fistula output

COMMA

Offset

Robotic Surgery in Living Donor Liver Transplantation,al specialties. Nevertheless, MIS has remained unpopular among hepatic surgeons, who perform only a minority of hepatic resections by MIS. The difficulty of access for fine dissection in deep anatomical locations, concerns about limited maneuverability, risk of major bleeding during transection and

Offset

Assessment of Tumour Response to Neoadjuvant Therapy for the Treatment of Oesophageal Cancer,ed oesophageal cancer (OC) as it has been shown to improve patient survival when compared with surgery alone [1]. The potential advantages of neoadjuvant therapy include downstaging of the primary tumour to facilitate resection with clear margins and to treat systemic micro-metastatic disease [2].

拱形大橋

Proton Beam Therapy in Gastrointestinal Cancers: A Paradigm Shift in Radiotherapy,Conventional X-ray-based radiation therapy for gastrointestinal (GI) cancers has been associated with not insignificant toxicity to surrounding organs at risk (OAR). Proton therapy has the potential to minimise this. There has been a recent rise in the number of facilities worldwide offering proton

Indict

Immunosuppression in Liver Transplantation,still rudimentary. Immunosuppression was developed by surgeons, about the middle of the last century, battling with biological forces that nobody understood and often in the face of opposition from those who thought they did. The primary function of the immune system—to defend the body from invasion

remission

Advances in Gastrointestinal Surgery,e small bowel obstruction, chemoradiotherapy for oesophageal carcinoma, pain in chronic pancreatitis, cystic tumours of the pancreas, targeted therapy in gastric cancer, acute necrotizing pancreatitis, surgery for failed ileoanal pouch, predicting mortality after surgery in patients with cirrhosis,